Market News AIOpen the app

COLL stock news · Collegium Pharmaceutical, Inc.

Stories about Collegium Pharmaceutical, Inc. (COLL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for COLL

Follow Collegium Pharmaceutical, Inc. (COLL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for COLL
Free on the App Store and Google Play, or on the web.
  1. Nov 13, 2026, 5:44 PM ET · Opinion

    Barclays has cut its price target for Collegium Pharmaceutical to $41, down from $48.

    Neutral

    Barclays lowered its share-price target for Collegium from $48 per share to $41 per share and kept its Overweight rating. The mixed analyst signals do not change the company's business outlook.